EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hydroxyflavone-Modified Aza-BODIPY Derivatives for Combined Photodynamic and CO Therapy against Neuroblastoma

Supapon Kwangmettatam, Bongkot Uengwanarat, Chaiyapat Nabglang, Kingsak Mahingsadet, Pishyaporn Sritangos, Prapassara Muangsopa iD, Charupong Saengboonmee iD, Rung-Yi Lai iD, Anyanee Kamkaew iD

Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 11900-11913

DOI: 10.1021/acs.jmedchem.5c03231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.05.2026. Verfasst von Supapon Kwangmettatam und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand. Hauptthemen laut MEDLINE: Photochemotherapy, Boron Compounds, Photosensitizing Agents, Carbon Monoxide. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Thailand Science Research and Innovation, Suranaree University of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyBoron CompoundsPhotosensitizing AgentsCarbon MonoxideNeuroblastomaAntineoplastic AgentsHumansAnimalsZebrafishCell Line, TumorSinglet OxygenApoptosis

Substanzen

Boron CompoundsPhotosensitizing AgentsCarbon MonoxideAntineoplastic AgentsazaBDPBA compoundSinglet Oxygen

Autor:innen und Institutionen

  • School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

ORCID-Profile: Prapassara Muangsopa, Charupong Saengboonmee, Rung-Yi Lai, Anyanee Kamkaew

Förderung

  • Thailand Science Research and Innovation
  • Suranaree University of Technology

Zitieren

APA

Kwangmettatam, S., Uengwanarat, B., Nabglang, C., Mahingsadet, K., Sritangos, P., Muangsopa, P., Saengboonmee, C., Lai, R. Y., & Kamkaew, A. (2026). Hydroxyflavone-Modified Aza-BODIPY Derivatives for Combined Photodynamic and CO Therapy against Neuroblastoma. Journal of Medicinal Chemistry, 69(10), 11900-11913. https://doi.org/10.1021/acs.jmedchem.5c03231

Vancouver

Kwangmettatam S, Uengwanarat B, Nabglang C, Mahingsadet K, Sritangos P, Muangsopa P, et al. Hydroxyflavone-Modified Aza-BODIPY Derivatives for Combined Photodynamic and CO Therapy against Neuroblastoma. Journal of Medicinal Chemistry. 2026;69(10):11900-11913. doi:10.1021/acs.jmedchem.5c03231

BibTeX
@article{Kwangmettatam2026,
  author = {Kwangmettatam, Supapon and Uengwanarat, Bongkot and Nabglang, Chaiyapat and Mahingsadet, Kingsak and Sritangos, Pishyaporn and Muangsopa, Prapassara and Saengboonmee, Charupong and Lai, Rung-Yi and Kamkaew, Anyanee},
  title = {Hydroxyflavone-Modified Aza-BODIPY Derivatives for Combined Photodynamic and CO Therapy against Neuroblastoma},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {10},
  pages = {11900--11913},
  doi = {10.1021/acs.jmedchem.5c03231}
}
Kostenlos starten →